Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Judson

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Anti-Cancer Drugs|January 12, 2000
Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimensJ Y Blay, I Judson, S Rodenhuis, et al.
Sarcoma|June 4, 2008
Treatment of epithelioid sarcoma at the royal marsden hospitalL Livi, N Shah, F Paiar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancerD C Talbot, I E Smith, J L Mansi, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomideP Beale, I Judson, S Moore, et al.
Oncogene|August 30, 2000
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperoneP A Clarke, I Hostein, U Banerji, et al.
British Journal of Cancer|November 20, 1998
Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694)I Judson, T Maughan, P Beale, et al.
British Journal of Cancer|April 3, 2003
A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)P Beale, I Judson, A O'Donnell, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group studyJ Verweij, I Judson, W Steward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigationI Judson, T Cerny, R Epelbaum, et al.
British Journal of Cancer|November 27, 1999
Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignanciesM Brada, I Judson, P Beale, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Anti-Cancer Drugs|January 12, 2000
Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimensJ Y Blay, I Judson, S Rodenhuis, et al.
Sarcoma|June 4, 2008
Treatment of epithelioid sarcoma at the royal marsden hospitalL Livi, N Shah, F Paiar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancerD C Talbot, I E Smith, J L Mansi, et al.
Cancer Chemotherapy and Pharmacology|September 29, 1999
Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomideP Beale, I Judson, S Moore, et al.
Oncogene|August 30, 2000
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperoneP A Clarke, I Hostein, U Banerji, et al.
British Journal of Cancer|November 20, 1998
Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694)I Judson, T Maughan, P Beale, et al.
British Journal of Cancer|April 3, 2003
A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)P Beale, I Judson, A O'Donnell, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group studyJ Verweij, I Judson, W Steward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigationI Judson, T Cerny, R Epelbaum, et al.
British Journal of Cancer|November 27, 1999
Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignanciesM Brada, I Judson, P Beale, et al.
Pageof 12